Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation

被引:24
作者
Hooley, E. [1 ]
McEwan, P. A. [1 ]
Emsley, J. [1 ]
机构
[1] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England
关键词
apple domain; high-molecular-weight kininogen; molecular model; plasma prekallikrein; zymogen activation;
D O I
10.1111/j.1538-7836.2007.02792.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prekallikrein (PK) plays a central role in the contact system that activates blood coagulation and is involved in the regulation of blood pressure.Objectives: To provide three-dimensional structural data for PK and rationalize the molecular basis of substrate recognition and zymogen activation.Patients/methods: The PK homology model was constructed using the coagulation factor (F) XI crystal structure as a template with the program SWISS-MODEL.Results: The domain organization of the PK apple domains and serine protease is conserved compared to FXI. Surface charge calculations on the PK model revealed that ligand binding to high-molecular-weight kininogen (HK) is predicted to have two key determinants: a pocket within the apple 2 domain and a basic channel formed at the interface of apple domains 1 and 4. A hereditary mutation resulting in PK deficiency (Gly104Arg) and the Lys140 alpha-kallikrein cleavage site both disrupt HK binding and are shown to map to opposite sides of the apple 2 domain pocket. The model also describes the differences in the apple 4 domain that prevents dimer formation in PK vs. FXI. A C-terminal extension in the PK serine protease domain is described as a potential substrate for prolylcarboxypeptidase.Conclusions: The interaction between PK and HK is mediated by two discrete surfaces formed by the PK A1, A2 and A4 domains with charge likely to be a critical component of the binding. A novel mode of PK activation is postulated to involve prolylcarboxypeptidase cleaving at the C-terminus rather than the activation loop.
引用
收藏
页码:2461 / 2466
页数:6
相关论文
共 33 条
[1]   IDENTIFICATION AND CHARACTERIZATION OF A BINDING-SITE FOR PLATELETS IN THE APPLE-3 DOMAIN OF COAGULATION-FACTOR-XI [J].
BAGLIA, FA ;
JAMESON, BA ;
WALSH, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6734-6740
[2]  
Baglia FA, 1996, J BIOL CHEM, V271, P3652
[3]  
BOUMA BN, 1977, J BIOL CHEM, V252, P6432
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   Are hemostasis and thrombosis two sides of the same coin? [J].
Colman, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03) :493-495
[6]  
COLMAN RW, 1985, BLOOD, V65, P311
[7]   Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor [J].
Colman, RW ;
Pixley, RA ;
Najamunnisa, S ;
Yan, WY ;
Wang, JY ;
Mazar, A ;
McCrae, KR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1481-1487
[8]   AMINO-ACID-SEQUENCE OF HUMAN FACTOR-XI, A BLOOD-COAGULATION FACTOR WITH 4 TANDEM REPEATS THAT ARE HIGHLY HOMOLOGOUS WITH PLASMA PREKALLIKREIN [J].
FUJIKAWA, K ;
CHUNG, DW ;
HENDRICKSON, LE ;
DAVIE, EW .
BIOCHEMISTRY, 1986, 25 (09) :2417-2424
[9]   The plasma kallikrein-kinin system and risk of cardiovascular disease in men [J].
Govers-Riemslag, J. W. P. ;
Smid, M. ;
Cooper, J. A. ;
Bauer, K. A. ;
Rosenberg, R. D. ;
Hack, C. E. ;
Hamulyak, K. ;
Spronk, H. M. H. ;
Miller, G. J. ;
Ten Cate, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) :1896-1903
[10]   MECHANISMS FOR INVOLVEMENT OF HIGH MOLECULAR-WEIGHT KININOGEN IN SURFACE-DEPENDENT REACTIONS OF HAGEMAN-FACTOR [J].
GRIFFIN, JH ;
COCHRANE, CG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (08) :2554-2558